Abstract:BACKGROUND: The role of programmed death 1 (PD-1) and programmed death ligand 1 (PD-L1) in persistent HBV infection is controversial. Increasing PD-1 and PD-L1 expression has been found in hepatitis B patients during immune clearance phase, but not in HBV-tolerant patients. We investigated PD-1 and PD-L1 expression and inflammation in chronic hepatitis B.METHODS: Twenty patients with chronic hepatitis B participated in this study. Fifteen patients were in the immune clearance phase, and 5 were in the immune inactive phase. Circulating HBV-specific T cells were analyzed by flow cytometric detection of major histocompatibility complex (MHC) class I peptide complexes, known as pentamers. Intra-hepatic PD-1 and PD-L1 expressions were analyzed by immunostaining.RESULTS: The frequency of pentamers, including core 18-27 (1.88%+/- 0.36%), env 335-343 (1.85%+/- 0.37%), and pol 575-583 (1.56%+/- 0.29%) was 8.30-, 7.71- and 8.48-fold greater during immune clearance phase than those during the immune inactive phase. In addition, more than 70% of circulating pentamers were PD-1 positive. During immune clearance phase, the numbers of intra-hepatic PD-1 and PD-L1 positive cells were 108 +/- 23/HPF and 97 +/- 20/HPF respectively, in contrast, there was a paucity of PD-1 and PD-L1 positive cells in the immune inactive phase. The numbers of intra-hepatic PD-1 and PD-L1 positive cells were positively correlated with serum alanine aminotransferase and the number of intra-hepatic CD8(+) T cells. Immunofluorescence showed that almost all of the intrahepatic CD8(+) T cells were PD-1 and CCR6 positive. These cells aggregated around macrophage inflammatory protein-3 alpha (MIP3 alpha) positive cells and mixed with PD-L1 positive cells.CONCLUSIONS: PD-1 and PD-L1 expressions were significantly correlated with inflammation. CCR6 and PD-1 co-expressed in the same cells; these cells were increased both in circulation and the inflamed liver and aggregated around MIP3a positive cells. The mixture of CCR6 and PD-1, MIP3a and PD-L1 positive cells created immune response compartments which played an important role in specific immune response in HBV immune clearance.

Increased PD-L1 Expression and PD-L1/CD86 Ratio on Dendritic Cells Were Associated with Impaired Dendritic Cells Function in HCV Infection.

Changes of Costimulatory Molecule CD28 on Circulating CD8+ T Cells Correlate with Disease Pathogenesis of Chronic Hepatitis B.

Functional impairment in circulating and intrahepatic NK cells and relative mechanism in hepatocellular carcinoma patients.

An Unbalanced PD-L1/CD86 Ratio in CD14(++)CD16(+) Monocytes is Correlated with HCV Viremia During Chronic HCV Infection.

[Impaired Non-Viral Specific Immune Function of Dendritic Cell Does Not Interfere with Clearance and Cytotoxic T Lymphocyte Response to HBV or HCV].

PD-1 expression on peripheral CD8+ TEM/TEMRA subsets closely correlated with HCV viral load in chronic hepatitis C patients

PD-1 Expression is Elevated in Monocytes from Hepatocellular Carcinoma Patients and Contributes to CD8 T Cell Suppression

Characteristics and PD-1 Expression of Peripheral CD4+CD127loCD25hiFoxP3+ Treg Cells in Chronic HCV Infected-Patients

[PD-L1 Expression in Circulating Dendritic Cells of Patients with Chronic Hepatitis B].

PD-1+ TIGIT+ CD8+ T cells are associated with pathogenesis and progression of patients with hepatitis B virus-related hepatocellular carcinoma

Decreased Numbers And Impaired Function Of Circulating Dendritic Cell Subsets In Patients With Chronic Hepatitis B Infection (R2)

Effect of regulatory T cells and adherent cells on the expansion of HBcAg-specific CD8+ T cells in patients with chronic hepatitis B virus infection

Study of Immune Function of Peripheral Blood Dendritic Cells from Chronic Hepatitis B Patients

PD-1 Upregulation is Associated with HBV-specific T Cell Dysfunction in Chronic Hepatitis B Patients.

CD4+ T cell exhaustion revealed by high PD-1 and LAG-3 expression and the loss of helper T cell function in chronic hepatitis B

Programmed Death 1 and Programmed Death Ligand 1 Expressions in Patients with Chronic Hepatitis B

The Unique Characteristic in Peripheral Immune Cells in Patients with Advanced Hepatocellular Carcinoma.

Study on the pathogenesis of HBeAg-positive chronic hepatitis B and plasmacytoid dendritic cells function

Hepatic compartmentalization of exhausted and regulatory cells in HIV/HCV-coinfected patients

Relationship Between PD-L1 Expression and CD8+ T-cell Immune Responses in Hepatocellular Carcinoma

Intrahepatic levels of PD-1/PD-L correlate with liver inflammation in chronic hepatitis B